How Much Does Kadcyla Cost?
Kadcyla (Ado-Trastuzumab Emtansine) costs an average of $14,515 per Medicare Part D claim, with total Medicare spending of $987.0M in the latest year. A generic version is available, which may reduce out-of-pocket costs.
Key Data
| Metric | Value |
|---|---|
| Avg Cost Per Claim | $14,515 |
| Total Medicare Spending | $987.0M |
| Total Claims | 68,000 |
| Beneficiaries | 8,400 |
| Generic Available | Yes |
| Year-Over-Year Change | -8.2% |
Kadcyla (Ado-Trastuzumab Emtansine) costs an average of $14,515 per Medicare Part D claim, with total Medicare spending of $987.0M in the latest year. A generic version is available, which may reduce out-of-pocket costs.